www.indivior.com
Open in
urlscan Pro
2a02:e980:d2::6a
Public Scan
Submitted URL: http://indivior.com/
Effective URL: https://www.indivior.com/en
Submission: On December 28 via manual from US — Scanned from DE
Effective URL: https://www.indivior.com/en
Submission: On December 28 via manual from US — Scanned from DE
Form analysis
1 forms found in the DOMGET /search
<form id="search-form" method="get" action="/search" role="search" class="search-form">
<div>
<fieldset>
<label for="query">Search this site</label>
<input type="hidden" name="lang" id="lang" value="en">
<input type="text" name="q" id="query" placeholder="Search here…" role="searchbox">
<button type="submit" aria-label="Search">Submit</button>
</fieldset>
<button type="button" aria-label="Cancel">Cancel</button>
</div>
</form>
Text Content
OUR USE OF COOKIES We use cookies so that we can improve the experience for visitors to our websites. This includes cookies that are necessary for the operation of our websites, as well as other cookies used for analytics purposes. We will not use analytical cookies unless you enable them. For more information about our use of cookies, please refer to our cookie policy. -------------------------------------------------------------------------------- ANALYTICS COOKIES These cookies allow us to understand how our websites are used, and to improve our websites over time. Enable analytics cookies: -------------------------------------------------------------------------------- Save and close * Skip to main content * Skip to search * Skip to navigation * Skip to footer * * Product Query and Adverse Event * International * Search * Menu Close INTERNATIONAL WEBSITES * International * Australia (English) * Canada (English) * Canada (French) * Denmark (Danish) * Finland (Finnish) * France (French) * Germany (German) * Israel (Hebrew) * Italy (Italian) * Norway (Norwegian) * Sweden (Swedish) * UK (English) Search this site Submit Cancel * About Us * ABOUT US * Our Approach * Our Leadership * Corporate Governance * Compliance With UK Governance Code * Committees * Global Conduct Policies * Internal Financial Control And Risk Management * Tax Strategy * Our Science * OUR SCIENCE * Therapeutic Focus Areas * Pipeline * Research and Development Publications * Externally Sponsored Studies and Independent Medical Education Grants * Indivior Charitable Contributions, Corporate Membership, and Corporate Collaborations * Products * Responsibility * RESPONSIBILITY * Approach * Environment & Climate Change * Workforce * Patient Safety & Product Quality * Corporate Integrity Agreement * Integrity & Compliance * Transparency Program * US Healthcare Providers * Business Conduct * Advocacy & Stakeholder Engagement * Sustainability Report * Investors * INVESTORS * Share Price & Tools * Results, Reports & Presentations * Alert Service * Financial Calendar * RNS filings * Shareholder Information * Dividends * Shareholder Meetings * ADR Information * Managing your shares * Demerger base cost * Prospectus * Share Repurchase Program * Contact Us (IR and Media) * Additional US Listing * Capital Markets Day * Our People * OUR PEOPLE * Careers * Locations * Working at Indivior * Our Guiding Principles * Media * MEDIA * Press Releases * Company Statements * Media Kit PATIENT NEEDS INSPIRE US Indivior is working to change patients' lives by developing medicines to treat substance use disorders and serious mental illnesses. About Us OUR 2021 SUSTAINABILITY REPORT Learn more about the steps we are taking to minimize our environmental impact, reach our goals for diversity and inclusion and lead on social impact through our mission to help patients. Find out more about the report LATEST NEWS December 7 2022 Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook Read more LATEST RESULTS December 7 2022 Indivior 2022 Capital Markets Day Read more SHARE PRICE CAREERS Accelerate your career by making a difference Read more OUR R&D ACTIVITIES Driving development in addressing addiction and behavioural health issues Read more NEWS AND MEDIA The latest information on Indivior Read more * * About Us * Investors * Media * Therapeutic Focus Areas * Responsibility * Careers * Our Approach * People * Contact Us * Locations * USEFUL LINKS * Product Query or Adverse Event * Modern Slavery Statement * Sitemap * Terms of Use * Privacy Policy * Accessibility * Privacy Policy and Notice for California Residents * Privacy Notice Healthcare Professionals * Cookie Policy * FOLLOW US * LinkedIn © 2022 Indivior PLC | This site is intended for US audiences | INDIVIOR is a registered trademark of Indivior UK Limited | Imagery for illustrative purposes only.